{"prompt": "['Quality of Life', 'Quality of life (QoL) will be measured in wart patients, using the Nepali version of', 'the dermatology life quality index (DLQI) questionnaire before initiation of', 'treatment and at the end of follow up. DLQI contains 10 questions that involves 6', 'sections: symptoms and feelings, daily activities, leisure, work and school,', 'personal relationships and treatment. Questions 1 and 2 assess symptoms and', 'feelings; 3 and 4, daily activities; 5 and 6, leisure; 7, work and school; 8 and 9,', 'personal relationships and 10, treatment.', 'The DLQI consists of 10 questions. Each question is given 4 options from not at', 'all effect (score 0) to very much effect (score 3). The minimum and maximum', \"possible score, thus, is 0 and 30 respectively. The interpretation of the patients'\", 'score is done as follows:', 'Meaning of DLQI Scores', \"0-1 = no effect at all on patient's life\", \"2-5 = small effect on patient's life\", \"6-10 = moderate effect on patient's life\", \"11-20 = very large effect on patient's life\", \"21-30 = extremely large effect on patient's life\", 'The clinically meaningful change or reduction in the DLQI score is measured as', 'the change in score from one band to the other in the above-mentioned', 'interpretation chart.', '25']['Statistical analysis', '1. Data handling: Data will be entered in Microsoft Excel 2010 (Microsoft', 'Corporation, Redmond, Washington, USA) and statistical analysis will be', 'done using Statistical Package for the Social Sciences 10.5 version', '(Chicago, Inc)', '2. Coding: Alpha numerical code will be used', '3. Monitoring: Data will be entered after every day of work and supervised by', 'guide.', '4. Statistical analysis will be conducted as per both per-protocol and', 'intention-to treat population (defined as all enrolled patients to whom study', 'drug will be given; with the last observation carried forward) basis using two', 'sided tests.', 'For descriptive statistics, percentage, mean, S.D., median, and minimum,', 'maximum will be calculated along with graphical and tabular presentation.', 'For inferential statistics, statistical methods that will be used are as follow', \"a. Chi square test and Fisher's exact test to compare the categorical data\", 'between the groups.', 'b. Paired t test for comparing normally distributed continuous variables', '(pretreatment and post treatment DLQI) at different time point within the', 'groups.', 'C. Mann- Whitney U test to compare the not normally distributed variables', '(age, duration of illness, size, number)', 'd. Kaplan-Meier curves to compare the response rate (complete, excellent,', 'good or poor response) on each follow up visit (week 3, 6, 9, 12) between', 'the groups.', '26']['Test of significance will be considered when value of p < 0.05.', 'REFERENCES', '1.', 'Kilkenny M, Marks R. The descriptive epidemiology of warts in the', 'community. Australas J Dermatol. 1996;37(2):80-86. loi:10.1111/j.1440-', '0960.1996.tb01010.x', '2.', 'Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-', \"Jones SE. British Association of Dermatologists' guidelines for the\", 'management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-', '712. toi:10.1111/bjd.13310', '3.', 'Bruggink SC, Eekhof JAH, Egberts PF, van Blijswijk SCE, Assendelft WJJ,', 'Gussekloo J. Natural course of cutaneous warts among primary', 'schoolchildren: A prospective cohort study. Ann Fam Med. 2013; 11(5):437-', '441. doi:10.1370/afm.1508', '4.', 'Leman JA, Benton EC. Verrucas Guidelines for Management. Bmj.', '2009;301(6763):1276-1277. doi:10.1136/bmj.301.6763.1276-', '5.', 'Dhope A, Madke B, Singh AL. Effect of Measles Mumps Rubella Vaccine in', 'Treatment of Common Warts. 2018;(2):81-84. doi:10.4103/ijdd.ijdd', '6.', 'Lipke MM. An armamentarium of wart treatments. Clin Med Res.', '2006;4(4):273-293. doi:10.3121/cmr.4.4.273', '7.', 'Salman S, Ahmed MS, Ibrahim AM, Mattar OM, El-Shirbiny H, Sarsik S, Afifi', 'AM, Anis RM, Yakoub Agha NA, Abushouk AI. Intralesional immunotherapy', 'for the treatment of warts: A network meta-analysis. J Am Acad Dermatol.', '2019 Apr;80(4):922-930.e4. doi: 10.101. doi:10.1016/j.jaad.2018.07.00', '8.', 'Nofal A, Nofal E, Yosef A, Nofal H. Treatment of recalcitrant warts with', '27']\n\n###\n\n", "completion": "END"}